NORDIC MEDICAL SOLUTIONS ApS: Financial statements 2023
CVR: 34352542
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
NORDIC MEDICAL SOLUTIONS ApS (CVR 34352542) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 45,365,516 and a net result of DKK 11,529,644 compared with DKK 22,210,531 the year before. That is a decrease of 11.7% compared with the year before. Equity in the 2023 report amounted to DKK 22,029,644. The solvency ratio was 37.3%. The company had 14 employees in the financial year.
- Gross Profit
- DKK 45,365,516
- Profit/Loss
- DKK 11,529,644
- Equity
- DKK 22,029,644
- Total Assets
- DKK 58,991,828
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 45.4M | 11.5M | 22M | 14 |
| 2022 | - | 51.4M | 22.2M | 31.2M | 10 |
| 2021 | - | 55.7M | 35.3M | 41.3M | 8 |
| 2020 | - | 34.5M | 19.4M | 22.4M | 9 |
| 2019 | - | 34.3M | 19.9M | 22.9M | 8 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout NORDIC MEDICAL SOLUTIONS ApS
NORDIC MEDICAL SOLUTIONS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named NORDIC PHARMA SOLUTIONS ApS. The management consists of Pernille Wandrup Rex. The board consists of Kim Erik Ginnerup (chair), Monica Reib, Pernille Wandrup Rex and Philip Fischer Stavnstrup. The company is owned by NMS Group A/S. The company has 16 employees (2026). In 2026, the company reported a gross profit of DKK 56,510,150 and a net result of DKK 31,681,814 compared with DKK 28,614,955 the year before. Equity in the 2026 report amounted to DKK 40,681,814.
